GENNVAX and GENNECS hosted the official summit, “Advancing Africa’s Health Security Through Sustainable Vaccine and Pharmaceutical Manufacturing,” bringing together leading national, continental, and global healthcare stakeholders.
The session highlighted Egypt’s growing role in vaccine and pharmaceutical localization through local manufacturing, regulatory excellence, technology transfer, and sustainable healthcare access. Strategic collaborations with Military Medical Services, Sinovac, Chumakov, and Ibn Sina further supported analytical testing, stability studies, clinical trial readiness, technology transfer, and vaccine manufacturing localization—strengthening the position of GENNVAX and GENNECS across Egypt and Africa.
Through biotechnology, local innovation, strategic partnerships, and sustainable vaccine manufacturing, they highlight how GENNVAX is helping build stronger regional capabilities, expand access to essential vaccines, and reduce dependence on imported solutions. Their message reflects a clear commitment to transforming collaboration and scientific innovation into greater health security, resilience, and self-sufficiency for Africa.
One Vision. Two Forces. Endless Impact.
GENNVAX and GENNECS hosted the official summit, “Advancing Africa’s Health Security Through Sustainable Vaccine and Pharmaceutical Manufacturing,” bringing together leading national, continental, and global healthcare stakeholders.
The session highlighted Egypt’s growing role in vaccine and pharmaceutical localization through local manufacturing, regulatory excellence, technology transfer, and sustainable healthcare access. Strategic collaborations with Military Medical Services, Sinovac, Chumakov, and Ibn Sina further supported analytical testing, stability studies, clinical trial readiness, technology transfer, and vaccine manufacturing localization—strengthening the position of GENNVAX and GENNECS across Egypt and Africa.